Recruitment

Recruitment Status
Not yet recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Rare Oligometastatic Cancers
Type
Interventional
Phase
Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04498767
Collaborators
Not Provided
Investigators
Principal Investigator: Matthias Guckenberger University of Zurich Principal Investigator: Piet Ost Universitair Ziekenhuis Gent